MAVENCLAD® (Cladribine Tablets) Approved As The First Short-Course Oral Treatment for Relapsing Remi

DARMSTADT, Germany, March 25, 2019 /PRNewswire/ -- -- MAVENCLAD(®) is now approved in 52 countries worldwide -- Approval brings forward new treatment option ... Lees verder

Bron:

ANP Pers support